Global Peripheral Stent System Market 2023-2030

    In Stock




    Angioplasty is a technique that opens clogged arteries using a catheter and a balloon.Stenting occurs following angioplasty, which involves a surgeon inserting a tiny metal device into the artery. The stent keeps the artery open and increases blood flow.


    In addition to these therapeutic options, the surgeon may utilize an atherectomy device to remove the plaque.


    Peripheral angioplasty and stenting are procedures that unblock a restricted or obstructed artery in extremities, such as arms or legs. This technique has the potential to eliminate the need for more invasive treatments like bypass surgery.


    Endovascular intervention is suggested when debilitating claudication persists after effective medical treatment, or when there is significant limb ischemia with ischemic rest discomfort or ischemic tissue loss.


    The use of endovascular procedures in the treatment of peripheral artery disease has increased significantly, with femoropopliteal treatments accounting for more than of cases. 


    The femoropopliteal artery traverses two joint structures (the hip and knee joints) and runs through the thigh’s muscle adductor canal, putting the artery under higher stress from twisting, bending, and longitudinal and radial compression stresses.


    Stents in the femoropopliteal system have historically been linked to higher rates of stent fracture, which is linked to higher rates of restenosis and a lower primary patency rate during long-term follow-up. 



    Infographic: Peripheral Stent System Market, Peripheral Stent System Market Size, Peripheral Stent System Market Trends, Peripheral Stent System Market Forecast, Peripheral Stent System Market Risks, Peripheral Stent System Market Report, Peripheral Stent System Market Share

    The Global Peripheral Stent System Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    BIOTRONIK announced that their unique Pulsar-18 T3 peripheral self-expanding stent system has obtained FDA clearance for an enhanced insertion process for endovascular treatments. The business also announced the device’s official commercial debut in the United States, which would begin soon.


    The Pulsar-18 T3 stent system is the first to integrate three technologies. When compared to 6-French devices, a 4-French low-profile delivery system may lower the likelihood of access site difficulties and the necessity for closure devices.1.


    The tri-axial system with braided shaft design makes it easier to insert the clinically validated Pulsar stent. The Pulsar-18 stent, with its small struts and low chronic outward force (COF)2,3,4, contributes to a lower mean area of restenosis 3,4.


    The newly built Pulsar-18 T3 stent system provides clinicians with an easy and ergonomic wheel-operated handle for one-handed stent release boosting the ability to manage deployment.


    The Pulsar-18 T3 stent system is intended for treatment in patients with symptomatic de novo, restenotic, or occlusive lesions in the superficial femoral or proximal popliteal arteries, with reference artery diameters ranging from mm and total lesion lengths ranging from 



    1. How many  Peripheral Stent Systems   are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Peripheral Stent System   and key vendor selection criteria
    3. Where is the Peripheral Stent System  manufactured? What is the average margin per unit?
    4. Market share of Global Peripheral Stent System   market  manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Peripheral Stent System   in-house
    6. 5 key predictions for next 5 years in Global Peripheral Stent System   market
    7. Average B-2-B  Peripheral Stent System market price in all segments
    8. Latest trends in  Peripheral Stent System market, by every market segment
    9. The market size (both volume and value) of the  Peripheral Stent System   market in 2023-2030 and every year in between?
    10. Production breakup of  Peripheral Stent System   market, by suppliers and their OEM relationship



    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop